Cargando…
Cardiac Insulin Signaling Regulates Glycolysis Through Phosphofructokinase 2 Content and Activity
BACKGROUND: The healthy heart has a dynamic capacity to respond and adapt to changes in nutrient availability. Diabetes mellitus disrupts this metabolic flexibility and promotes cardiomyopathy through mechanisms that are not completely understood. Phosphofructokinase 2 (PFK‐2) is a primary regulator...
Autores principales: | Bockus, Lee B., Matsuzaki, Satoshi, Vadvalkar, Shraddha S., Young, Zachary T., Giorgione, Jennifer R., Newhardt, Maria F., Kinter, Michael, Humphries, Kenneth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779029/ https://www.ncbi.nlm.nih.gov/pubmed/29203581 http://dx.doi.org/10.1161/JAHA.117.007159 |
Ejemplares similares
-
Insulin signaling alters antioxidant capacity in the diabetic heart
por: Matsuzaki, Satoshi, et al.
Publicado: (2021) -
Diabetes induced decreases in PKA signaling in cardiomyocytes: The role of insulin
por: Eyster, Craig A., et al.
Publicado: (2020) -
Increased cardiac PFK-2 protects against high-fat diet-induced cardiomyopathy and mediates beneficial systemic metabolic effects
por: Mendez Garcia, Maria F., et al.
Publicado: (2023) -
The loss of cardiac SIRT3 decreases metabolic flexibility and proteostasis in an age-dependent manner
por: Li, Ping, et al.
Publicado: (2022) -
Expression of Phosphofructokinase Is Not Sufficient to Enable Embden-Meyerhof-Parnas Glycolysis in Zymomonas mobilis ZM4
por: Felczak, Magdalena M., et al.
Publicado: (2019)